Tanya Simuni1, Chelsea Caspell-Garcia2, Christopher Coffey3, Shirley Lasch4, Caroline Tanner5, Ken Marek6. 1. Northwestern University Feinberg School of Medicine, United States. Electronic address: tsimuni@nmff.org. 2. The University of Iowa, United States. Electronic address: chelsea-caspell@uiowa.edu. 3. The University of Iowa, United States. Electronic address: christopher-coffey@uiowa.edu. 4. Institute for Neurodegenerative Disorders, United States. Electronic address: slasch@mnimaging.com. 5. University of California San Francisco, United States. Electronic address: caroline.tanner@ucsf.edu. 6. Institute for Neurodegenerative Disorders, United States. Electronic address: kmarek@mnimaging.com.
Abstract
OBJECTIVE: To determine the frequency and stability over time of the subgroup characterization of the tremor dominant (TD) versus postural instability gait disorder dominant (PIGD) Parkinson's disease (PD) in de novo patients. BACKGROUND: There is a substantial body of literature on the clinical sub classification of PD into TD versus PIGD subtype. However, there are limited data on the stability of this classification especially in early disease. METHODS: Parkinson's Progression Markers Initiative (PPMI) is a longitudinal case control study of de novo, untreated PD participants at enrollment. Participants undergo a number of assessments including the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS). TD versus PIGD subtype was defined based on the previously published formula. We report one-year analysis data. RESULTS: 320 of 423 PD recruited subjects had data on subtype classification at year 1 and were included in the analysis. 228 (71%) were classified as TD, 56 (18%) as PIGD and 36 (11%) as indeterminate at baseline. At 12 months, 39% PIGD and 18% TD shifted subtypes: 29% PIGD shifted to TD and 11% to Indeterminate; 10% TD shifted to PIGD and 8% to Indeterminate. The classification was not affected by the dopaminergic treatment (p = 0.59). CONCLUSIONS: TD versus PIGD subtype classification has substantial variability over first year in PD de novo cohort specifically for PIGD subtype. Dopaminergic therapy does not impact the change of the PD subtype. This instability has to be taken into consideration specifically when establishing correlations with the biomarkers and for long term prognostication.
OBJECTIVE: To determine the frequency and stability over time of the subgroup characterization of the tremor dominant (TD) versus postural instability gait disorder dominant (PIGD) Parkinson's disease (PD) in de novo patients. BACKGROUND: There is a substantial body of literature on the clinical sub classification of PD into TD versus PIGD subtype. However, there are limited data on the stability of this classification especially in early disease. METHODS:Parkinson's Progression Markers Initiative (PPMI) is a longitudinal case control study of de novo, untreated PDparticipants at enrollment. Participants undergo a number of assessments including the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS). TD versus PIGD subtype was defined based on the previously published formula. We report one-year analysis data. RESULTS: 320 of 423 PD recruited subjects had data on subtype classification at year 1 and were included in the analysis. 228 (71%) were classified as TD, 56 (18%) as PIGD and 36 (11%) as indeterminate at baseline. At 12 months, 39% PIGD and 18% TD shifted subtypes: 29% PIGD shifted to TD and 11% to Indeterminate; 10% TD shifted to PIGD and 8% to Indeterminate. The classification was not affected by the dopaminergic treatment (p = 0.59). CONCLUSIONS: TD versus PIGD subtype classification has substantial variability over first year in PD de novo cohort specifically for PIGD subtype. Dopaminergic therapy does not impact the change of the PD subtype. This instability has to be taken into consideration specifically when establishing correlations with the biomarkers and for long term prognostication.
Authors: Robert S Eisinger; Christopher W Hess; Daniel Martinez-Ramirez; Leonardo Almeida; Kelly D Foote; Michael S Okun; Aysegul Gunduz Journal: Parkinsonism Relat Disord Date: 2017-07-21 Impact factor: 4.891
Authors: Alberto J Espay; Michael A Schwarzschild; Caroline M Tanner; Hubert H Fernandez; David K Simon; James B Leverenz; Aristide Merola; Alice Chen-Plotkin; Patrik Brundin; Marcelo A Kauffman; Roberto Erro; Karl Kieburtz; Daniel Woo; Eric A Macklin; David G Standaert; Anthony E Lang Journal: Mov Disord Date: 2017-02-24 Impact factor: 10.338
Authors: Lan Luo; Howard Andrews; Roy N Alcalay; Fernanda Carvalho Poyraz; Amelia K Boehme; Jennifer G Goldman; Tao Xie; Paul Tuite; Claire Henchcliffe; Penelope Hogarth; Amy W Amara; Samuel Frank; Margaret Sutherland; Catherine Kopil; Anna Naito; Un Jung Kang Journal: Parkinsonism Relat Disord Date: 2019-06-23 Impact factor: 4.891
Authors: Ee Wei Lim; Dag Aarsland; Dominic Ffytche; Raquel Natalia Taddei; Daniel J van Wamelen; Yi-Min Wan; Eng King Tan; Kallol Ray Chaudhuri Journal: J Neurol Date: 2018-10-30 Impact factor: 4.849